McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet. 1998;352:1137–40.

Article  CAS  PubMed  Google Scholar 

Kolarz B, Podgorska D, Podgorski R. Insights of rheumatoid arthritis biomarkers. Biomarkers. 2021;26:185–95.

Article  CAS  PubMed  Google Scholar 

Schoels MM, Braun J, Dougados M, Emery P, Fitzgerald O, Kavanaugh A, et al. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis. 2014;73:238–42.

Article  CAS  PubMed  Google Scholar 

Hsieh P-H, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann Rheum Dis. 2020;79:771–7.

Article  PubMed  Google Scholar 

Byford S. Economic note: cost of illness studies. BMJ. 2000;320:1335.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Angiolella LS, Cortesi PA, Lafranconi A, Micale M, Mangano S, Cesana G, et al. Cost and cost effectiveness of treatments for psoriatic arthritis: a systematic literature review. Pharmacoeconomics. 2018;36:567–89.

Article  PubMed  Google Scholar 

Antonazzo IC, Gribaudo G, La Vecchia A, Ferrara P, Piraino A, Cortesi PA, et al. Cost and cost effectiveness of treatments for psoriatic arthritis: an updated systematic literature review. Pharmacoeconomics. 2024;42:1329–43.

Article  PubMed  Google Scholar 

Cortesi PA, Scalone L, D’Angiolella L, Belisari A, Fusco F, Olivieri I, et al. Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis. Clin Exp Rheumatol. 2012;30(4 Suppl. 73):S126–31.

PubMed  Google Scholar 

Burgos-Pol R, Martínez-Sesmero JM, Ventura-Cerdá JM, Elías I, Caloto MT, Casado MÁ. The cost of psoriasis and psoriatic arthritis in 5 European countries: a systematic review. Actas Dermosifiliogr. 2016;107:577–90.

Article  CAS  PubMed  Google Scholar 

Palla I, Trieste L, Tani C, Talarico R, Cortesi PA, Mosca M, et al. A systematic literature review of the economic impact of ankylosing spondylitis. Clin Exp Rheumatol. 2012;30(4 Suppl. 73):S136–41.

PubMed  Google Scholar 

Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20:327.

Article  PubMed  PubMed Central  Google Scholar 

Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics. 2011;29:653–71.

Article  PubMed  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339: b2700.

Article  PubMed  PubMed Central  Google Scholar 

McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012. https://doi.org/10.1016/j.jocd.2012.03.005.

Article  Google Scholar 

Shemilt I, James T, Marcello M. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy. 2010;6:51–9.

Article  Google Scholar 

Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 2009;12:409–18.

Article  PubMed  Google Scholar 

Lachin JM. Power and sample size evaluation for the Cochran–Mantel–Haenszel mean score (Wilcoxon rank sum) test and the Cochran-Armitage test for trend. Stat Med. 2011;30:3057–66.

Article  PubMed  Google Scholar 

Tsifetaki N, Migkos MP, Papagoras C, Voulgari PV, Athanasakis K, Drosos AA. Counting costs under severe financial constraints: a cost-of-illness analysis of spondyloarthropathies in a tertiary hospital in Greece. J Rheumatol. 2015;42:963–7.

Article  PubMed  Google Scholar 

Bagepally BS, Kumar SS, Sasidharan A, Haridoss M, Venkataraman K. Household catastrophic health expenditures for rheumatoid arthritis: a single centre study from South India. Sci Rep. 2023;13:15385.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tu L, Rai JC, Cao S, Lin Z, Hu Z, Gu J. Costs and work limitation of patients with ankylosing spondylitis in China. Clin Exp Rheumatol. 2014;32(5):661–6.

PubMed  Google Scholar 

Koster F, Bakx PLH, Kok MR, Barreto DL, Weel-Koenders AEAM. Multimorbidity status and annual healthcare expenditures of rheumatoid arthritis patients: a Dutch hospital-centered versus population-based comparison. Rheumatol Int. 2023;43(6):1067–76.

Article  PubMed  PubMed Central  Google Scholar 

Petříková A, Doležal T, Klimeš J, Vocelka M, Šedová L, Kolář J. The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008. Rheumatol Int. 2013;33:1813–9.

Article  PubMed  Google Scholar 

Mennini FS, Marcellusi A, Gitto L, Iannone F. Economic burden of rheumatoid arthritis in Italy: possible consequences on anti-citrullinated protein antibody-positive patients. Clin Drug Investig. 2017;37:375–86.

Article  PubMed  Google Scholar 

Younes M, Jalled A, Aydi Z, Zrour S, Korbaa W, Ben Salah Z, et al. Socioeconomic impact of ankylosing spondylitis in Tunisia. Joint Bone Spine. 2010;77:41–6.

Article  PubMed  Google Scholar 

Kobelt G, Sobocki P, Mulero J, Gratacos J, Pocovi A, Collantes-Estevez E. The burden of ankylosing spondylitis in Spain. Value Health. 2008;11:408–15.

Article  PubMed  Google Scholar 

Schorling E, Lick S, Steinberg P, Brüggemann DA. Health care utilizations and costs of Campylobacter enteritis in Germany: a claims data analysis. PLoS ONE. 2023;18: e0283865.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azevedo VF, Rossetto CN, Lorencetti PG, Tramontin MY, Fornazari B, Araújo DV. Indirect and direct costs of treating patients with ankylosing spondylitis in the Brazilian public health system. Revista Brasileira de Reumatologia (Engl Ed). 2016;56:131–7.

Article  Google Scholar 

Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65:1175–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boonen A. Costs of ankylosing spondylitis in three European countries: the patient’s perspective. Ann Rheum Dis. 2003;62:741–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ogdie A, Hwang M, Veeranki P, Portelli A, Sison S, Shafrin J, et al. Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis. J Manag Care Spec Pharm. 2022;28:1008–20.

PubMed  Google Scholar 

Torres TM, Ferraz MB, Ciconelli RM. Resource utilisation and cost of ankylosing spondylitis in Brazil. Clin Exp Rheumatol. 2010;28(4):490–7.

CAS  PubMed  Google Scholar 

Krüger K, Von Hinüber U, Meier F, Tian H, Böhm K, Jugl SM, et al. Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. Rheumatol Int. 2018;38:2121–31.

Article  PubMed  Google Scholar 

Brodszky V, Bálint P, Géher P, Hodinka L, Horváth G, Koó É, et al. Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment. Rheumatol Int. 2009;30:199–205.

Article  PubMed  Google Scholar 

Raciborski F, Śliwczyński A, Kłak A, Kwiatkowska B, Brzozowska M, Tłustochowicz M. Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system: the case of Poland. Rheumatology. 2016;54:278–84.

Article  PubMed